Soluble CD44-mediated cellular responses to lipopolysaccharide

Chemical Immunology

Volumn 74, Issue , 1999, Pages 108-121

  Tapping, Richard I ^a   Tobias, Peter S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE; CELL SURFACE RECEPTOR; DROSOPHILA PROTEIN; ISOPROTEIN; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR;

CELL ACTIVATION; CELLULAR IMMUNITY; ENDOTHELIUM CELL; PRIORITY JOURNAL; REVIEW; ANIMAL; C3H MOUSE; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; GENETICS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; MOUSE; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SOLUBILITY; STRUCTURE ACTIVITY RELATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD14; DROSOPHILA PROTEINS; ENDOTHELIUM, VASCULAR; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; PROTEIN ISOFORMS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TOLL-LIKE RECEPTORS;

EID: 0033631344     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bone RC: Gram-negative sepsis. Background, clinical features, and intervention. Chest 1991;100:802-808.
2. Glauser MP, Zanetti G, Baumgartner J-D, Cohen J: Septic shock: Pathogenesis. Lancet 1991;338:732-736.
3. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N: Cultured human endothelial cells generate tissue factor in response to endotoxin. Clin Invest 1983;71:1893-1896.
4. Schleimer RP, Rutledge BK: Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol 1986;136:649-654.
5. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM: An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol 1986;136:4548-4553.
6. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238-9242.
7. Dustin ML, Springer TA: Lymphocyte function-associated antigen (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988;107:321-331.
8. Carlos TM, Schwartz BR, Kovach NL, Yee E, Rosa M, Osborn L, Chi-Rosso G, Newman B, Lobb R: Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990;76[5]:965-970.
9. Stern DM, Bank I, Nawroth PP, Cassimeris J, Kisiel W, Fenton JW, Dinarello C, Chess L, Jaffe EA: Self-regulation of procoagulant events on the endothelial cell surface. J Exp Med 1985;162:1223-1235.
10. Miossec P, Cavender D, Ziff M: Production of interleukin 1 by human endothelial cells. J Immunol 1986;136:2486-2491.
11. Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA: Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986;124:179-185.
12. Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, Lotz M: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989;142:144-147.
13. Loppnow H, Libby P: Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1. Cell Immunol 1989;122:493-503.
14. Harlan JM, Harker LA, Reidy MA, Gajdusek CM, Schwartz SM, Striker GE: Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest 1983;48:269-274.
15. Meyrick BO, Ryan US, Brigham KL: Direct effects of E. coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am J Pathol 1986;122:140-151.
16. Bazil V, Horejsi V, Hilgert I, McMichael MJ (eds): Leucocyte Typing III. White Cell Differentiation Antigens. The Workshop: Myeloid Panel Antibodies Recognizing the 53-kDa Molecular Weight Monocyte Antigen (CD14). Oxford, Oxford University Press, 1982, p. 611-613.
17. Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger J, Kostka W, Hilgert I: Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 1986;16:1583-1589.
18. Stelter F, Pfister M, Bernheiden M, Jack RS, Bufler P, Engelmann H, Schutt C: The myeloid differentiation antigen CD14 is N- and O-glycosylated: Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur J Biochem 1996;236:457-464.
19. Bazil V, Baudys M, Hilgert I, Stefanova I, Low M, Brozek J, Horejsi V: Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol 1989;26:657-662.
20. Bazil V, Strominger JL: Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991;147:1567-1574.
21. Labeta MO, Durieux J, Fernandez N, Herrmann R, Ferrara P: Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol 1993;23:2144-2151.
22. Durieux J-J, Vita N, Popescu O, Guette F, Calzada-Wack J, Munker R, Schmidt RE, Lupker J, Ferrara P, Ziegler-Heitbrock HWL, et al: The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes. Eur J Immunol 1994;24:2006-2012.
23. Bufler P, Stiegler G, Schuchmann M, Hess S, Kruger C, Stelter F, Eckerskorn C, Schutt C, Engelmann H: Soluble lipopolysaccharide receptor (CD 14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol 1995;25:604-610.
24. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding proteins. Science 1990;249:1431-1433.
25. Beekhuizen H, Blokland I, Corsel-van Tilburg AJ, Koning F, van Furth R: CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol 1991;147:3761-3767.
26. Patrick D, Betts J, Frey EA, Prameya R, Dorovini-Zis K, Finlay BB: Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway. J Infect Dis 1992;165:865-872.
27. von Asmuth EJU, Leeuwenberg JFM, Ceska M, Buurman WA: LPS and cytokine-induced endothelial cell IL-6 release and ELAM-1 expression: Involvement of serum. Eur Cytokine Net 1991;2:291-297.
28. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD: Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176:1665-1671.
29. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS: Lipopolysaccharide (LPS) activation of human endothelial and epithelial cells is mediated by LPS binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90:2744-2748.